Category: Hologic Inc.Syndicate content

Hologic beats with Q4 earnings, ditches MRI coils biz

November 6, 2014 by Brad Perriello

Hologic's 4th-quarter and fiscal 2014 earnings top expectations as it reveals the sale of its MRI coils business to Philips Healthcare.

Hologic beats with Q4, 2014 earnings, ditches MRI coils biz

Medicare OKs reimbursement codes for 3D mammography

November 3, 2014 by Brad Perriello

The Centers for Medicare & Medicaid Services approve new reimbursement codes for mammograms using 3D breast tomosynthesis technology, sending Hologic shares up today on Wall Street.

Medicare OKs reimbursement codes for Hologic 3D mammography

MRI Interventions taps Intuitive Surgical's Grillo for CEO | Personnel Moves

September 11, 2014 by Brad Perriello

MRI Interventions taps Intuitive Surgical marketing & business development executive Frank Grillo to be its new CEO.

MRI Interventions taps Intuitive Surgical's Grillo for CEO | Personnel Moves

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Hologic CEO gives glowing review to major stakeholder and activist investor Carl Icahn | Medtech Wall Street news for the week of August 4, 2014

August 7, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Hologic's CEO praises its activist investor; Lantheus spikes IPO plans; Ex-CEO Pignatelli backs down, but not out, in spat with Biolase; Symmetry Medical sells its OEM biz to Tecomet for $450M; Valeant's hostile takeover hopes fade as Allergan war continues

Hologic's CEO praises its activist investor

August 4, 2014 by Arezu Sarvestani

Hologic CEO MacMillan praises activist investor Icahn

Hologic's CEO praises its activist investor

August 4, 2014 by Arezu Sarvestani

Hologic CEO Steven MacMillan says activist investor Carl Icahn, who pushed his way into the board room last year, is "clearly not a micro-manager."

Hologic CEO MacMillan praises activist investor Icahn

Hologic (NSDQ:HOLX) CEO Steven MacMillan offered a glowing review to major stakeholder Carl Icahn, saying that activist investor is "not into our shorts at all."

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Hologic swings to Q3 black

August 1, 2014 by Brad Perriello

Hologic swings to fiscal 3rd-quarter profits despite flat sales growth and raises its sales and earnings forecasts for the rest of fiscal 2014.

Hologic swings to Q3 black

Hologic (NSDQ:HOLX) swung to 3rd-quarter black during the 3 months ended June 28, despite flat sales growth of just 1%, and boosted its outlook for the rest of its fiscal year.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp